ClariVest Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $9.76M | Hold |
|
|||||
|
2024
Q2 | $9.76M | Buy |
|
|||||
|
2024
Q1 | $8.34M | Buy |
|
|||||
|
2023
Q4 | $4.1M | Sell |
|
|||||
|
2023
Q3 | $4.08M | Buy |
|
|||||
|
2023
Q2 | $3M | Sell |
|
|||||
|
2023
Q1 | $3.61M | Sell |
|
|||||
|
2022
Q4 | $3.79M | Sell |
|
|||||
|
2022
Q3 | $3.48M | Buy |
|
|||||
|
2022
Q2 | $3M | Sell |
|
|||||
|
2022
Q1 | $3.86M | Buy |
|
|||||
|
2021
Q4 | $782K | Buy |
|
|||||
|
2021
Q3 | $861K | Buy |
|
|||||
|
2021
Q2 | $865K | Sell |
|
|||||
|
2021
Q1 | $1.06M | Sell |
|
|||||
|
2020
Q4 | $923K | Sell |
|
|||||
|
2020
Q3 | $864K | Buy |
|
|||||
|
2020
Q2 | $966K | Buy |
|
|||||
|
2020
Q1 | $467K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $154K | Sell |
|
|||||
|
2018
Q4 | $156K | Sell |
|
|||||
|
2018
Q3 | $251K | Buy |
|